Tenderwize
Back to tender search

Open House Discount Contracts for Amifampridin (ATC N07XX05)

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 195 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Amifampridin, ATC N07XX05

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount contracts for Amifampridin (ATC N07XX05) to be supplied to the AOK Rheinland-Pfalz/Saarland.
  • Standardized contract terms; no negotiations.
Show full summary

This is a non-exclusive open-house procedure for pharmaceutical discount contracts for the active ingredient Amifampridin (ATC N07XX05), organized by AOK Rheinland-Pfalz/Saarland. The procedure allows any interested pharmaceutical company to enter into standardized discount agreements without competitive selection. Contracts run up to 24 months from the earliest start date (01.05.2025) and can be terminated automatically if the buyer awards exclusive contracts. The notice is published voluntarily for transparency and is not subject to EU procurement law despite using the standard form.

Risks

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Pharmaceutical companies must be authorized to market Amifampridin in Germany.
  • Drugs must be approved and marketable in Germany, proven by Lauer-Taxe listing or AMIce database extracts.

Administrative

  • Physical submission of signed contract documents; electronic submission not allowed.

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open House Discount Contracts for Amifampridin (ATC N07XX05)

Non-exclusive discount contracts for Amifampridin with standardized terms. No negotiations, no exclusivity. Contracts end at the latest 24 months after the first contract start (01.05.2025), regardless of individual start dates. The buyer may replace these contracts with exclusive contracts at any time, causing automatic termination.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Feb 28, 2027

Procurement Details

Publication date
12 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
164018-2025

Documents (1)

Similar tenders